Clarithromycin Stops Lung Function Decline in Airway-Centered Interstitial Fibrosis | Zendy

S. Jouneau | Zendy; M. Kerjouan | Zendy; Sylvie Caulet-Maugendre | Zendy; Stéphanie Guillot | Zendy; Catherine Meunier | Zendy; B. Desrues | Zendy; P. Delaval | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clarithromycin Stops Lung Function Decline in Airway-Centered Interstitial Fibrosis

Author(s) -

S. Jouneau,

M. Kerjouan,

Sylvie Caulet-Maugendre,

Stéphanie Guillot,

Catherine Meunier,

B. Desrues,

P. Delaval

Publication year - 2012

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000341982

Subject(s) - medicine , lung transplantation , clarithromycin , airway , lung , fibrosis , lung function , cystic fibrosis , pulmonary fibrosis , interstitial lung disease , idiopathic pulmonary fibrosis , pulmonary function testing , surgery , helicobacter pylori

Airway-centered interstitial fibrosis (ACIF) is a distinct type of lung interstitial fibrosis characterized by lesions centered on the airways. Several cases reported in the literature showed little to no effect of corticosteroids and a high mortality rate in the absence of lung transplantation. No other efficient approach is described for the treatment of this type of fibrosis. We report for the first time the case of a 44-year-old patient diagnosed with ACIF on surgical lung biopsy and stabilized with clarithromycin after failure of systemic corticosteroids. We need to confirm this benefit in other patients to ascertain the anti-inflammatory effect of macrolides, which are far less harmful compared to corticosteroids or immunosuppressant drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research